Why is Jenburkt Pharma falling/rising?

As of 12-September, Jenburkt Pharmaceuticals Ltd. is experiencing a rise in its stock price, currently at 1,098.50, reflecting an increase of 29.05 or 2.72%. Today's performance indicates a trend reversal as the stock has gained after four consecutive days of decline. It outperformed its sector by 2.45%, reaching an intraday high of Rs 1100. However, despite this uptick, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The company benefits from high management efficiency, evidenced by a return on equity (ROE) of 18.49%, and maintains a low debt-to-equity ratio, which supports its financial stability.
In the broader market context, Jenburkt Pharmaceuticals has underperformed compared to the Sensex over the past week, month, and year, with returns of -7.12%, -4.04%, and -2.54% respectively, while the Sensex has shown positive returns in those periods. However, the stock has demonstrated strong performance over the longer term, with a 3-year return of +81.57% and a 5-year return of +209.39%, significantly outpacing the benchmark. The recent rise in investor participation, with a 12.28% increase in delivery volume, suggests a growing interest in the stock, which could be contributing to its current price movement.